World Vaccine Congress Europe 2025 - Progress Clinical Research Skip to main content

World Vaccine Congress Europe 2025

13-16 oktober 2025

Amsterdam, the Netherlands

The World Vaccine Congress 2025, organized by Terrapinn, is a leading event for professionals in the vaccine industry. The congress offers a comprehensive programme with over 250 sessions, including workshops, lectures, and debates on the latest developments and challenges in the field. This event provides a unique opportunity to build valuable connections, exchange knowledge, and gain insights into the latest breakthroughs in research, clinical trials, and vaccine production.

Read more about this event via the button below.

Meet us at this event

This is a great opportunity to meet each other or even catch up, exchange ideas, and discover what else we do. We look forward to seeing you at this event.

CEO and Neurologist

Niels Prins

CEO and Neurologist

Meet our Chief Executive Officer

Niels is our CEO and oversees the strategic and operational management of Progress Clinical Research. This is a great opportunity to engage personally with Niels, who serves as the point of contact for major business decisions and collaborations. Ask your questions, share your ideas, and learn more about our vision and services. He also plays a crucial role in driving innovation and growth within our company.

Send e-mail
LinkedIn

Clinical Trial Start-up Specialist

Peter Jongste

Clinical Trial Start-up Specialist

Meet our Clinical Trial Start-up Specialist

Peter plays an important role in the setup and execution of clinical trials at Progress Clinical Research. This event offers a great opportunity to engage directly with our specialist, who is responsible for coordinating start-up activities and ensuring a smooth and efficient initiation of clinical studies. Ask your questions, share your ideas, and discover how we collaborate with our clients to achieve successful clinical trials. We look forward to meeting you at the World Vaccine Congress on 13-16 october. See you then!

Send e-mail
LinkedIn